Assembly Biosciences Inc (ASMB)
17.05
+0.35
(+2.10%)
USD |
NASDAQ |
Nov 14, 16:00
16.79
-0.26
(-1.52%)
After-Hours: 20:00
Assembly Biosciences Research and Development Expense (Quarterly): 16.26M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 16.26M |
| March 31, 2024 | 11.88M |
| December 31, 2023 | 11.01M |
| September 30, 2023 | 10.82M |
| June 30, 2023 | 12.52M |
| March 31, 2023 | 14.55M |
| December 31, 2022 | 16.85M |
| September 30, 2022 | 18.13M |
| June 30, 2022 | 17.79M |
| March 31, 2022 | 17.20M |
| December 31, 2021 | 14.75M |
| September 30, 2021 | 18.47M |
| June 30, 2021 | 16.75M |
| March 31, 2021 | 18.55M |
| December 31, 2020 | 33.51M |
| September 30, 2020 | 26.94M |
| June 30, 2020 | 23.33M |
| March 31, 2020 | 23.05M |
| December 31, 2019 | 22.62M |
| September 30, 2019 | 21.74M |
| June 30, 2019 | 18.70M |
| March 31, 2019 | 22.70M |
| December 31, 2018 | 21.25M |
| September 30, 2018 | 19.11M |
| June 30, 2018 | 17.84M |
| Date | Value |
|---|---|
| March 31, 2018 | 14.54M |
| December 31, 2017 | 10.60M |
| September 30, 2017 | 10.93M |
| June 30, 2017 | 12.12M |
| March 31, 2017 | 10.57M |
| December 31, 2016 | 8.622M |
| September 30, 2016 | 8.833M |
| June 30, 2016 | 7.519M |
| March 31, 2016 | 8.119M |
| December 31, 2015 | 5.226M |
| September 30, 2015 | 4.630M |
| June 30, 2015 | 4.668M |
| March 31, 2015 | 3.834M |
| December 31, 2014 | 2.975M |
| September 30, 2014 | 3.672M |
| June 30, 2014 | 1.096M |
| March 31, 2014 | 2.974M |
| December 31, 2013 | 5.158M |
| September 30, 2013 | 3.753M |
| June 30, 2013 | 3.508M |
| March 31, 2013 | 2.609M |
| December 31, 2012 | 2.741M |
| September 30, 2012 | 4.188M |
| June 30, 2012 | 6.162M |
| March 31, 2012 | 6.423M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
10.82M
Minimum
Sep 2023
33.51M
Maximum
Dec 2020
18.16M
Average
17.20M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| ADMA Biologics Inc | 0.412M |
| Sensus Healthcare Inc | 0.866M |
| Protagonist Therapeutics Inc | 35.97M |
| Precision BioSciences Inc | 13.08M |
| Entrada Therapeutics Inc | 31.26M |